These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10476769)

  • 21. Investigation of an outbreak of influenza by A/Vict./3/75 (H3N2) virus strain in Kharakwasla in 1980.
    Bhattacharya SR; Rai J; Suri PN; Krishna K; Shukla RN
    Indian J Pathol Microbiol; 1983 Apr; 26(2):77-80. PubMed ID: 6654448
    [No Abstract]   [Full Text] [Related]  

  • 22. Influenza vaccine: the challenge of antigenic drift.
    Carrat F; Flahault A
    Vaccine; 2007 Sep; 25(39-40):6852-62. PubMed ID: 17719149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged influenza virus infection during lymphocytopenia and frequent detection of drug-resistant viruses.
    Gooskens J; Jonges M; Claas EC; Meijer A; Kroes AC
    J Infect Dis; 2009 May; 199(10):1435-41. PubMed ID: 19392620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans.
    Koelle K; Cobey S; Grenfell B; Pascual M
    Science; 2006 Dec; 314(5807):1898-903. PubMed ID: 17185596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antigenic and genetic study of hemagglutinin gene of influenza virus (H3N2) circulated in China in 2004].
    Shu YL; Zhang Y; Wen LY; Li Z; Guo JF; Wang M; Yu HJ; Yang WZ; Guo YJ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Dec; 19(4):362-5. PubMed ID: 16415996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Serological survey on antibodies to influenza A viruses subtype H1, H3, H5 and H9 of population in Shanghai].
    Lv XH; Jiang CY; Zhou YB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Mar; 30(3):302. PubMed ID: 19642392
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunogenicity and tolerability of inactivated flu vaccine in high risk and healthy children.
    Avila Aguero ML; Soriano-Fallas A; Umaña-Sauma MA; Ulloa-Gutierrez R; Arnoux S
    Medicina (B Aires); 2007; 67(4):351-9. PubMed ID: 17891930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Preparation and characteristics of the antigenic properties of tissue influenza diagnostic agents].
    Sominina AA; Korchanova NL; Lisok TP; Rumel' NB; Sverdlov AB
    Tr Inst Im Pastera; 1982; 59():67-70. PubMed ID: 7187571
    [No Abstract]   [Full Text] [Related]  

  • 29. Influenza in Canada: 2005-2006 season.
    Reyes F; Macey JF; Aziz S; Li Y; Watkins K; Winchester B; Zabchuck P; Zheng H; Huston P; Tam TW; Hatchette T
    Can Commun Dis Rep; 2007 Feb; 33(3):21-41. PubMed ID: 17323533
    [No Abstract]   [Full Text] [Related]  

  • 30. Antigenic analysis of influenza A viruses.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1981 Mar; 30(9):110-1. PubMed ID: 6789137
    [No Abstract]   [Full Text] [Related]  

  • 31. Egg-grown and tissue-culture-grown variants of influenza A (H3N2) virus with special attention to their use as antigens in seroepidemiology.
    Pyhälä R; Pyhälä L; Valle M; Aho K
    Epidemiol Infect; 1987 Dec; 99(3):745-53. PubMed ID: 3428377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antigen load and storability of sensitized microtiter plates for influenza virus ELISA].
    Rosmus K; Griessmann K; Borkhardt HL
    Z Gesamte Hyg; 1985 Nov; 31(11):649-50. PubMed ID: 4090550
    [No Abstract]   [Full Text] [Related]  

  • 33. Update: influenza activity--United States, September 28, 2008-April 4, 2009, and composition of the 2009-10 influenza vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Apr; 58(14):369-74. PubMed ID: 19373198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antigenic heterogeneity of human influenza virus type A populations and its role in the epidemic process].
    Beliakov VD; Golubev DB; Zuev VA; Karpukhin GI; Medvedeva MN
    Vestn Akad Med Nauk SSSR; 1983; (5):23-8. PubMed ID: 6191450
    [No Abstract]   [Full Text] [Related]  

  • 35. [Biological and epidemiological aspects of the persistence of the influenza virus].
    Golubev DB; Medvedeva MN
    Vestn Akad Med Nauk SSSR; 1983; (5):34-9. PubMed ID: 6868803
    [No Abstract]   [Full Text] [Related]  

  • 36. Virological analysis of a case of dual infection by influenza A (H3N2) and B viruses.
    Shimada S; Sadamasu K; Shinkai T; Kakuta O; Kikuchi Y; Shinohara M; Uchida K; Doi R; Kohmoto K; Shimizu M; Nakajima S
    Jpn J Infect Dis; 2006 Feb; 59(1):67-8. PubMed ID: 16495643
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of twenty rapid antigen tests for the detection of human influenza A H5N1, H3N2, H1N1, and B viruses.
    Taylor J; McPhie K; Druce J; Birch C; Dwyer DE
    J Med Virol; 2009 Nov; 81(11):1918-22. PubMed ID: 19774693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative analytical sensitivities of six rapid influenza A antigen detection test kits for detection of influenza A subtypes H1N1, H3N2 and H5N1.
    Chan KH; Lam SY; Puthavathana P; Nguyen TD; Long HT; Pang CM; Chan KM; Cheung CY; Seto WH; Peiris JS
    J Clin Virol; 2007 Feb; 38(2):169-71. PubMed ID: 17194622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Influenza activity in China from 2000 to 2001].
    Zhang Y; Li Z; Guo JF; Wang M; Wen LY; Guo YJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jan; 24(1):4-8. PubMed ID: 12678953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigenic characterisation of H3N2 subtypes of the influenza virus by mass spectrometry.
    Morrissey B; Streamer M; Downard KM
    J Virol Methods; 2007 Nov; 145(2):106-14. PubMed ID: 17588679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.